ThinkEquity
http://www.thinkequity.comThinkEquity offers research, investment banking, wealth management, and asset management services for institutional and individual investors.
View Older Stories View More Recent Stories
-
Murchinson Issues Letter to Fellow Shareholders Encouraging Them to See Through Nano Dimension’s Deceptive Scare Tactics and Make Their Voices Heard
-
Beamr Imaging Ltd. Announces Closing of Initial Public Offering
-
Beamr Imaging Ltd. Announces Closing of Initial Public Offering
-
Beamr Imaging (BMR) Prices 1.95M Share IPO at $4/sh
-
Beamr Imaging Ltd. Announces Pricing of Initial Public Offering
-
Beamr Imaging Ltd. Announces Pricing of Initial Public Offering
-
KWESST Generates New Regional Opportunities at IDEX 2023
-
Tivic Health Systems, Inc. Announces Closing of Public Offering
-
Alliance Entertainment Completes Business Combination with Adara Acquisition Corp.
-
Blink Charging Announces Closing of Public Offering of Common Stock for Gross Proceeds of $100 Million
-
Tivic Health Systems (TIVC) prices 20m shares at $0.25
-
Tivic Health Systems, Inc. Announces Pricing of Public Offering
-
Lirum Therapeutics Announces Closing of $7 Million Private Placement of Common Stock
-
Lirum Therapeutics Announces Closing of $7 Million Private Placement of Common Stock
-
Blink Charging (BLNK) prices 8.33m shares at $12
-
Blink Charging Announces Pricing of its Upsized Public Offering of Common Stock
-
Society Pass (Nasdaq: SOPA) Engages ThinkEquity to Facilitate Stock Repurchase Program of Up to US$2 Million Commencing on 01 February 2023
-
Society Pass (Nasdaq: SOPA) Engages ThinkEquity to Facilitate Stock Repurchase Program of Up to US$2 Million Commencing on 01 February 2023
-
DCS Announces Launch of Initial Public Offering for Uplisting to NYSE American
-
1847 Holdings’ Subsidiary, 1847 Cabinets Inc., Engages ThinkEquity to Explore Strategic Alternatives
-
ProPhase Labs Closes Acquisition of BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test
-
ProPhase Labs (PRPH) Acquires Rights to Novel Esophageal Cancer Test
-
ProPhase Labs Acquires Rights to Novel Esophageal Cancer Test
-
Netcapital Inc. Announces Closing of Public Offering
-
Nexcella, Inc. in-licenses NXC-201, BCMA-targeted Next-Generation CAR-T Therapy Demonstrating High Complete Response Rate in Heavily Pre-Treated Multiple Myeloma (71% Complete Responses) and AL Amyloi
-
Nexcella, Inc. in-licenses NXC-201, BCMA-targeted Next-Generation CAR-T Therapy Demonstrating High Complete Response Rate in Heavily Pre-Treated Multiple Myeloma (71% Complete Responses) and AL Amyloi
-
Immix Biopharma (IMMX) in-licenses NXC-201, BCMA-targeted Next-Generation CAR-T Therapy Demonstrating High Complete Response Rate in Heavily Pre-Treated Multiple Myeloma and AL Amyloidosis
-
Immix Biopharma in-licenses NXC-201, BCMA-targeted Next-Generation CAR-T Therapy Demonstrating High Complete Response Rate in Heavily Pre-Treated Multiple Myeloma (71% Complete Responses) and AL Amylo
-
Immix Biopharma in-licenses NXC-201, BCMA-targeted Next-Generation CAR-T Therapy Demonstrating High Complete Response Rate in Heavily Pre-Treated Multiple Myeloma (71% Complete Responses) and AL Amylo
-
Netcapital (NCPL) prices 1.247 million share offering at $1.40
-
Netcapital Inc. Announces Pricing of Public Offering
-
Netcapital (NCPL) Announces Proposed Public Offering of Common Stock
-
Netcapital Inc. Announces Proposed Public Offering of Common Stock
-
KWESST Micro Systems Inc. Announces Closing of Public Offerings for $14.1 Million in Aggregate Gross Proceeds
-
KWESST Micro Systems Inc. Announces Closing of Public Offerings for USD $14.1 Million in Aggregate Gross Proceeds
-
Joseph Gunnar Announces the Addition of Ryan Konik to Lead its Institutional Sales Team
-
KWESST Micro Systems (KWE) Prices 2.5M Units at $4.13
-
KWESST Confirms Details of the US IPO and Canadian Offering
-
KWESST Micro Systems Inc. Announces Pricing of Public Offering and Nasdaq Listing
-
OKYO Pharma Limited ("OKYO" or the "Company") - OKYO publicly files a registration statement with the SEC
-
OKYO Pharma Limited ("OKYO" or the "Company") - OKYO publicly files a registration statement with the SEC
-
ThinkEquity Starts Vivani Medical, Inc. (VANI) at Buy, 'Novel Long-Term Therapeutic Implants for Chronic Diseases'
-
Direct Communication Solutions, Inc. Announces Filing of Registration Statement for Proposed Initial Public Offering and Application for Uplisting to NYSE American
-
HeartBeam Reports Third Quarter 2022 Financial Results
-
FAT Brands (FAT) Announces Proposed Stock Offering, Size not Disclosed
-
FAT Brands Announces Proposed Public Offering of Class A Common Stock
-
FAT Brands Announces Proposed Public Offering of Class A Common Stock
-
Vitro Biopharma (VTRO) Announces Proposed IPO
-
Mobilicom to Present at ThinkEquity Investor Conference
-
Mobilicom to Present at ThinkEquity Investor Conference

